D. Stephenson

713 total citations
18 papers, 558 citations indexed

About

D. Stephenson is a scholar working on Psychiatry and Mental health, Social Psychology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Stephenson has authored 18 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 5 papers in Social Psychology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Stephenson's work include Schizophrenia research and treatment (8 papers), Mental Health Treatment and Access (5 papers) and Lung Cancer Treatments and Mutations (5 papers). D. Stephenson is often cited by papers focused on Schizophrenia research and treatment (8 papers), Mental Health Treatment and Access (5 papers) and Lung Cancer Treatments and Mutations (5 papers). D. Stephenson collaborates with scholars based in United Kingdom, United States and Canada. D. Stephenson's co-authors include Jan McKendrick, Tom Burns, Christopher M. Thompson, Robert Peveler, Gavin Young, Ruth Filik, Helen Stevens, J. Donoghue, Timothy R. Hylan and Rodney L. Dunn and has published in prestigious journals such as American Journal of Psychiatry, Psychological Medicine and European Journal of Cancer.

In The Last Decade

D. Stephenson

18 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Stephenson United Kingdom 12 255 128 79 79 75 18 558
Dale A. D’Mello United States 11 146 0.6× 40 0.3× 29 0.4× 14 0.2× 59 0.8× 23 309
Malcolm Forbes Australia 14 82 0.3× 35 0.3× 62 0.8× 41 0.5× 47 0.6× 42 467
Tasneem Khambaty United States 17 88 0.3× 41 0.3× 19 0.2× 47 0.6× 64 0.9× 37 590
Martin K. Chen United States 6 225 0.9× 25 0.2× 60 0.8× 14 0.2× 42 0.6× 10 438
Ranjit C. Chacko United States 13 279 1.1× 46 0.4× 64 0.8× 4 0.1× 160 2.1× 32 676
Carolyn Levinson United States 6 189 0.7× 165 1.3× 50 0.6× 4 0.1× 130 1.7× 7 583
Joan M. Anzia United States 8 418 1.6× 112 0.9× 48 0.6× 4 0.1× 208 2.8× 16 701
Ziggy Yoediono United States 6 147 0.6× 131 1.0× 61 0.8× 3 0.0× 59 0.8× 6 511
R. H. Cawley United Kingdom 11 121 0.5× 63 0.5× 46 0.6× 7 0.1× 111 1.5× 27 554
Emmanuel Wiernik France 16 75 0.3× 34 0.3× 18 0.2× 15 0.2× 92 1.2× 52 622

Countries citing papers authored by D. Stephenson

Since Specialization
Citations

This map shows the geographic impact of D. Stephenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Stephenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Stephenson more than expected).

Fields of papers citing papers by D. Stephenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Stephenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Stephenson. The network helps show where D. Stephenson may publish in the future.

Co-authorship network of co-authors of D. Stephenson

This figure shows the co-authorship network connecting the top 25 collaborators of D. Stephenson. A scholar is included among the top collaborators of D. Stephenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Stephenson. D. Stephenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Stephenson, D. & Bruce P. Halpern. (2008). No Oral-Cavity-Only Discrimination of Purely Olfactory Odorants. Chemical Senses. 34(2). 121–126. 18 indexed citations
2.
Laugharne, Richard, et al.. (2007). Measurement of quality of life in schizophrenia: a comparison of two scales. Social Psychiatry and Psychiatric Epidemiology. 42(10). 819–823. 27 indexed citations
3.
Chaplin, Robert, et al.. (2006). The impact of intellectual functioning on symptoms and service use in schizophrenia. Journal of Intellectual Disability Research. 50(4). 288–294. 16 indexed citations
4.
Filik, Ruth, Attila Sipos, Patrick G. Kehoe, et al.. (2006). The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatrica Scandinavica. 113(4). 298–305. 111 indexed citations
5.
Burns, Tom, Stephen Cooper, Glynn Harrison, et al.. (2005). Maintenance antipsychotic medication patterns in outpatient schizophrenia patients: a naturalistic cohort study. Acta Psychiatrica Scandinavica. 113(2). 126–134. 19 indexed citations
6.
7.
McCreadie, Robin G., Helen Stevens, John Henderson, et al.. (2004). The dental health of people with schizophrenia. Acta Psychiatrica Scandinavica. 110(4). 306–310. 113 indexed citations
8.
Lees, Michael, et al.. (2003). Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK. The European Journal of Health Economics. 4(3). 216–221. 12 indexed citations
9.
Aristides, M, et al.. (2002). Economic Evaluation of Gemcitabine Alone and in Combination with Cisplatin in the Treatment of Nonsmall Cell Lung Cancer. PharmacoEconomics. 20(5). 325–337. 34 indexed citations
10.
Botwood, N., J McKendrick, M Aristides, et al.. (2001). Economic evaluation of Gemzar/cisplatin relative to other cisplatin based treatments for non small cell lung (NSCLC) cancer in the UK. European Journal of Cancer. 37. S233–S233. 1 indexed citations
11.
Botwood, N., J McKendrick, M Aristides, et al.. (2001). CN4: ECONOMIC EVALUATION OF GEMZAR/CISPLATIN RELATIVE TO OTHER CISPLATIN BASED TREATMENTS FOR NON SMALL CELL LUNG (NSCLC) CANCER IN THE UK. Value in Health. 4(2). 54–55. 1 indexed citations
12.
13.
Aristides, M, N. Botwood, J McKendrick, et al.. (2001). PCN9: ECONOMIC EVALUATION OF GEMZAR/CISPLATIN RELATIVE TO OTHER NEW AGENTS FOR NON SMALL CELL LUNG CANCER (NSCLC) IN THE UK. Value in Health. 4(2). 87–87. 1 indexed citations
14.
Stephenson, D., et al.. (2000). The impact of antidepressants on sleep and anxiety: a comparative study of fluoxetine and dothiepin using the Leeds Sleep Evaluation Questionnaire. Human Psychopharmacology Clinical and Experimental. 15(7). 529–534. 11 indexed citations
15.
Thompson, Christopher M., Robert Peveler, D. Stephenson, & Jan McKendrick. (2000). Compliance With Antidepressant Medication in the Treatment of Major Depressive Disorder in Primary Care: A Randomized Comparison of Fluoxetine and a Tricyclic Antidepressant. American Journal of Psychiatry. 157(3). 338–343. 81 indexed citations
16.
Dunn, Rodney L., J. Donoghue, Ronald J. Ozminkowski, D. Stephenson, & Timothy R. Hylan. (1999). Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines. Journal of Psychopharmacology. 13(2). 136–143. 82 indexed citations
17.
McKendrick, Jan, D. Stephenson, C. Thompson, & R.C. Peveler. (1998). Compliance with antidepressant treatment of depression in primary care in the UK. European Neuropsychopharmacology. 8. S202–S203. 1 indexed citations
18.
Stephenson, D., Jonathan S.E. Hellewell, Rhiannon Corcoran, Chris Frith, & J.F.W. Deakin. (1996). Theory of mind and other cognitive deficits in schizophrenia. Schizophrenia Research. 18(2-3). 206–206. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dale A. D’Mello Breakdown of academic impact, for papers by Malcolm Forbes Breakdown of academic impact, for papers by Tasneem Khambaty Breakdown of academic impact, for papers by Martin K. Chen Breakdown of academic impact, for papers by Ranjit C. Chacko Breakdown of academic impact, for papers by Carolyn Levinson Breakdown of academic impact, for papers by Joan M. Anzia Breakdown of academic impact, for papers by Ziggy Yoediono Breakdown of academic impact, for papers by R. H. Cawley Breakdown of academic impact, for papers by Emmanuel Wiernik
Rankless by CCL
2026